To validate our results from the KP cell tumor model, we used Lewis lung carcinoma (LLC1) cells in CB2-/- vs. WT mice and identified that tumor burden was significantly reduced in CB2-/- mice when compared to WT mice (Figure S2C). The gene discussed is CNR2; the disease is neoplasm.